M&A Deal Summary

LucyRx Acquires CerpassRx

On July 31, 2025, LucyRx acquired life science company CerpassRx

Acquisition Highlights
  • This is LucyRx’s 1st transaction in the Life Science sector.
  • This is LucyRx’s 1st transaction in the United States.
  • This is LucyRx’s 1st transaction in Texas.

M&A Deal Summary

Date 2025-07-31
Target CerpassRx
Sector Life Science
Buyer(s) LucyRx
Deal Type Add-on Acquisition

Target

CerpassRx

The Colony, Texas, United States
CerpassRx is a full-service, pharmacy benefit manager that offers prescription optimization, flexible formulary designs, personalized member support, and efficient mail and specialty pharmacy programs. CerpassRx is based in The Colony, Texas.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

LucyRx

Bethesda, Maryland, United States

Category Company
Sector Internet Software and Services
DESCRIPTION

LucyRx is a pharmacy benefit manager (PBM) redefining prescription care that delivers better outcomes through its integrated specialty network, formulary marketplace, and next-day home delivery solutions. Powered by its proprietary AI platform, LucyIQ, the company provides real-time insights that support evidence-based clinical decisions, clear pricing, and exceptional service from U.S.-based pharmacy technicians. LucyRx is based in Bethesda, Maryland.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1